Setup and characterization of a high-throughput luminescence-based serum bactericidal assay (l-sba) to determine functionality of human sera against shigella flexneri

HIGHLIGHTS

• who: Francesca Mancini and collaborators from the GSK Vaccines Institute for Global Health srl (GVGH), via Fiorentina, Siena, Italy have published the research: Setup and Characterization of a High-Throughput Luminescence-Based Serum Bactericidal Assay (L-SBA) to Determine Functionality of Human Sera against Shigella flexneri, in the Journal: BioTech 2022, 29 of 27/07/2022
• what: Written informed consent was obtained before enrollment from the subjects and the trial was designed and conducted in accordance with the Good Clinical Practice Guidelines and the Declaration of Helsinki.
• how: The authors expect that it . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.